Stock NAOV NANOVIBRONIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NanoVibronix, Inc.

Equities

NAOV

US63008J6038

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.7585 USD +1.13% Intraday chart for NanoVibronix, Inc. -5.19% -34.04%
Apr. 08 NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 233.7 185.8 50.12 32.25 8.264 2.353
Enterprise Value (EV) 1 232.8 184.5 43.01 24.56 5.632 -0.9247
P/E ratio -51 x -3.41 x -1.82 x -1.83 x -1.31 x -0.54 x
Yield - - - - - -
Capitalization / Revenue 735 x 351 x 80.5 x 19 x 11 x 1.03 x
EV / Revenue 732 x 348 x 69 x 14.5 x 7.49 x -0.41 x
EV / EBITDA -54.4 x -35.8 x -9.12 x -4.32 x -1.18 x 0.3 x
EV / FCF -110 x -98.8 x 815 x -6.23 x -1.23 x 0.52 x
FCF Yield -0.91% -1.01% 0.12% -16.1% -81% 194%
Price to Book 505 x 149 x 12 x 4.61 x 2.56 x 0.59 x
Nbr of stocks (in thousands) 3,226 3,260 3,280 1,550 1,640 2,046
Reference price 2 72.42 57.00 15.28 20.80 5.040 1.150
Announcement Date 4/15/19 5/20/20 4/15/21 4/15/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.318 0.53 0.623 1.695 0.752 2.283
EBITDA 1 -4.279 -5.147 -4.717 -5.681 -4.754 -3.075
EBIT 1 -4.285 -5.151 -4.719 -5.683 -4.755 -3.076
Operating Margin -1,347.48% -971.89% -757.46% -335.28% -632.33% -134.73%
Earnings before Tax (EBT) 1 -4.281 -5.811 -4.31 -14.25 -5.413 -3.682
Net income 1 -4.154 -5.794 -4.325 -14.28 -5.448 -3.711
Net margin -1,306.29% -1,093.21% -694.22% -842.6% -724.47% -162.55%
EPS 2 -1.421 -16.70 -8.400 -11.35 -3.838 -2.120
Free Cash Flow 1 -2.121 -1.867 0.0528 -3.945 -4.564 -1.793
FCF margin -667.02% -352.22% 8.47% -232.74% -606.87% -78.53%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/15/19 5/20/20 4/15/21 4/15/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.9 1.34 7.11 7.69 2.63 3.28
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -2.12 -1.87 0.05 -3.94 -4.56 -1.79
ROE (net income / shareholders' equity) -203% -640% -231% -328% -114% -103%
ROA (Net income/ Total Assets) -83.1% -178% -57.5% -42.2% -41% -30.6%
Assets 1 4.998 3.254 7.526 33.88 13.29 12.12
Book Value Per Share 2 0.1400 0.3800 1.270 4.510 1.970 1.950
Cash Flow per Share 2 0.2800 0.3800 3.790 5.530 1.650 1.600
Capex 1 0.01 - 0 0 0 0
Capex / Sales 2.52% - 0.32% 0.18% 0.4% 0.04%
Announcement Date 4/15/19 5/20/20 4/15/21 4/15/22 4/17/23 4/8/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NANOVIBRONIX, INC. Stock NanoVibronix, Inc.
-34.04% 2.11M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NAOV Stock
  4. Financials NanoVibronix, Inc.